Publisher: Bentham Science Publishers
E-ISSN: 1875-5917|5|1|11-26
ISSN: 1568-0088
Source: Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol.5, Iss.1, 2005-01, pp. : 11-26
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Neurodegeneration in multiple sclerosis
PHARMAKON, Vol. 2, Iss. 6, 2014-11 ,pp. :
Neurodegeneration and Neuroprotection in Multiple Sclerosis
Current Pharmaceutical Design, Vol. 18, Iss. 29, 2012-10 ,pp. :
Therapeutic developments in multiple sclerosis
By Goodin D.S.
Expert Opinion on Investigational Drugs, Vol. 9, Iss. 4, 2000-04 ,pp. :